0% found this document useful (0 votes)
26 views32 pages

Immunisation

The document discusses immunization, including types of vaccines, the Malaysian National Immunisation Programme, and the advantages and disadvantages of active and passive immunization. It outlines various vaccine types such as live attenuated, inactivated, and nucleic acid vaccines, along with their mechanisms and examples. Additionally, it highlights the role of adjuvants in enhancing immune responses and details the Malaysian immunization schedule for childhood diseases.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
26 views32 pages

Immunisation

The document discusses immunization, including types of vaccines, the Malaysian National Immunisation Programme, and the advantages and disadvantages of active and passive immunization. It outlines various vaccine types such as live attenuated, inactivated, and nucleic acid vaccines, along with their mechanisms and examples. Additionally, it highlights the role of adjuvants in enhancing immune responses and details the Malaysian immunization schedule for childhood diseases.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

L19: IMMUNISATION

Nor Afifah Supardy, Ph.D


Unit of Microbiology
Aimst University
LEARNING OBJECTIVES
To discuss the types of immunisation, vaccines, and national immunisation
schedules of Malaysia

TOPIC OUTOCOMES
 19.1 Analyse the advantages and disadvantages of active immunisation and
passive immunsation
 19.2 List the types of vaccines (live attenuated, inactivated, protein
based, viral vector and nucleic acid) with suitable examples
 19.3 Discuss childhood immunisation with reference to Malaysian
immunization schedule
 19.4 Recall primary and secondary immune response
 19.5 Recognise the role of adjuvants
.
Immunisation
 Definition: The process of giving a vaccine to a person to protect them
against diseases or resistant to an infectious disease, typically by
administering vaccines
 Immunity by immunisation is similar to the immunity a person would
get from disease, but instead of getting the disease, you get a vaccine
 Immunity - organism’s ability to protect itself from anything that it
does not recognize as self, such as a pathogen or toxin
 Vaccine – a suspension of organisms or fractions of organisms used to
induce immunity
ADVANTAGES AND DISADVANTAGES OF ACTIVE
IMMUNIZATION AND PASSIVE IMMUNIZATION
 Active immunisation – Immunity is acquired actively when a person is
exposed to microorganisms or foreign substances and the person’s
immune system responds
- Induction of immunity after exposure to an antigen
- Natural – exposure to microbe
- Artificial – use of vaccine

 Passive immunisation – Immunity is acquired passively when antibodies


are transferred from one person to another
- the immunity in recipient lasts only as long as the antibodies are
present
- Natural – mother to fetus (transplacental transfer), colostrum
- Artificial – Use of immunoglobulins
Genetic or Acquired during
natural Immunity
lifetime as a result
immunity, born of exposure to
with antigens

Innate Adaptive
Immunity Immunity

Artificial
Natural

Active Passive
Active
Antigens enter the Passive
Antibodies pass Antigens are introduced
body naturally; from mother to Preformed
in vaccines; body
body induces fetus via placenta antibodies in
produces antibodies and
antibodies and or to infant via the immune serum are
specialized lymphocytes
specialized mother’s milk introduced by
lymphocytes injection
Innate Immunity Adaptive Immunity
Genetic or natural immunity, born Acquired during lifetime as a result of exposure
with to antigens (infection/vaccination)
Immediate response, lifelong - Slower, taking days or weeks to develop for first
protection time
- Retain a long term “memory” and faster
response if encountered again
Types Types
• First line & second line defenses • Third line defenses
• First line defenses - Physical and • Active immunity – acquired from first hand-
chemical barriers including skin, exposure through infection or vaccination
eyelashes, tears, mucous, stomach that activate individual immune system
acid • Passive immunity – acquired by receiving
• Second line defenses – external antibodies
interferons, interleukin 1, • natural - mother to baby through placenta
phagocytes, natural killer cells • artificial – from medicine, gamma globulin
injection
Advantages & Disadvantages

Chickenpox Covid-19 , influenza

Advantages:
- Last longer, create memory B Advantages:
cells - Immediate boost to fight disease
- Less costly
Disadvantages: Disadvantages:
- Longer development time for - Temporary immunity
immunity (days to weeks) - Costly
- No protection against mutations
DESCRIBE THE TYPES OF VACCINES
Principles & effects:
 Vaccines: Weakened or dead form of a pathogen or its subunits used to stimulate the
immune system to generate an immune response
 Vaccination: A simple, safe, and effective way of protecting you against harmful diseases,
before you come into contact with them.
 Vaccines train the immune system to create antibodies, just as it does when the body is
exposed to a disease
 How does a vaccine work? When you get a vaccine, your immune system;
1. Recognizes the invading germ (bacteria or virus)
2. Produces antibodies
3. Remembers the disease and how to fight it in future exposure. Immune system can
quickly destroy it.
 Vaccines contain only killed/weakened forms of pathogen, they don not cause the
disease/risk of complications/illness
Types of Vaccines
1. Live attenuated vaccines
2. Inactivated/Killed vaccines
3. Subunit/Cellular fractions
4. Toxoid vaccines
5. DNA vaccines
6. Recombinant vector vaccines
1. Live Attenuated Vaccine
 Live vaccines
 Whole bacteria/virus that have been weakened (attenuated)
 To create a protective immune response without cause disease in healthy people
 More potent than other vaccines
 Contain all major and minor antigenic components
 Engage body tissues causing persistent & excellent immune response
 Contraindication – immunocompromised/pregnancy – may cause infections
 Examples: Chickenpox, measles, mumps, rubella, herpes zoster

Body creates
Virus is modified & antibodies to
weakened so it can still fight off the
replicate but no longer impaired form
cause illness of virus
2. Inactivated/Killed Vaccines
 Organisms are killed by heat or chemical (formalin/phenol) and injected into
body
 Pathogens are intact for immune system to recognize, but can not replicate
 Safe, less efficacious, requires adjuvants
 Requires booster dose
 Examples: Hepatitis A, poliomyelitis, rabies

3. Subunit/Protein Vaccines
 Contain selected antigenic fragments of pathogen that best stimulate immune
response
 Can be bacteria/virus components OR desired antigenic fractions from genetically
modified nonpathogenic microbes (recombinant vaccines)
 No risk of infection, safe to administer in immunocompromised, pregnant woman
 Examples: Hepatitis B, human papillomavirus
3. Toxoid Vaccines
 Contain inactivated toxins produced by pathogens
 Toxicity is lost but antigenicity is retained
 Antibody response against the inactivated toxins
 Examples: Tetanus, diphtheria – part of standard childhood immunization
series

4. Nucleic Acid/DNA Vaccines


 Newest & most promising
 Virus DNA that encodes specific protein antigens is injected into
patient
 Patient’s body synthesizes the antigen  antigen is recognized as foreign 
trigger immune system  body produce antibody
 In clinical trials: Influenza A, Ebola, West Nile Virus, SARS, Zika virus
5. Recombinant Vector Vaccines
 Similar to DNA vaccines except use of a vector
 Use of attenuated and live virus/bacterium as vector to introduce microbial
DNA to the body
 Examples: Hepatitis B.
 In clinical trials: Influenza, HIV,
Hepatitis C.

Bacterial cell

Figure: How DNA vaccine are produced and injected


CHILDHOOD IMMUNIZATION
(MALAYSIAN IMMUNIZATION SCHEDULE)
The Malaysian National Immunisation
Programme (NIP)
 The NIP was introduced in early 1950s
 Designed based on World Health Organisation (WHO) Expanded
Programme on Immunisation (EPI), recommend all countries immunise
against 6 childhood diseases
 NIP protects Malaysian children against 13 major diseases
 NIP vaccinations are free-of-charge at all government clinics & payable at
private clinics
 When to get vaccinations? According to NIP schedule
13 Diseases Preventable Under NIP
Diseases Description
1. Diphteria An infectious disease caused by bacteria that live in the mouth and
throat of the infected person.
2. Haemophilus influenzae A serious infection that mainly affects children under 5 years.
type B (Hib)
3. Hepatitis B Infection of the liver by the Hepatitis B virus.
4. Human papillomavirus Most common sexually transmitted infection (STI) that causes
(HPV) cervical cancer which is the third most common cancer in women.
5. Japanese encephalitis Infection of the brain caused by JE virus.
(JE)
6. Measles A highly contagious viral disease.
7. Mumps A viral infection that is the most common cause of inflammation of
the brain (encephalitis).
8. Pertussis – Whooping Highly contagious, with violent and persistent coughing that may
Cough cause a child to struggle to breathe and, turn blue (cyanosed).
9. Poliomyelitis (polio) An infectious and incurable viral disease that attacks the nervous
system.
Diseases Description
10. Rubella Also known as German measles that may cause abnormalities to the
foetus.
11. Tetanus Also known as lockjaw, caused by bacteria toxins that attacks the body’s
nervous system.
12. Tuberculosis (TB) A disease that commonly infects the lungs, but can also attack other
parts such as the kidney, spine, skin, intestines and brain.
13. Pneumococcal A bacterial infection caused by Streptococcus pneumoniae that can
affect the lungs and other parts of the body.

Source: https://immunise4life.my/the-malaysian-national-immunisation-programme-nip/
Jadual Immunisasi Kebangsaan

Source: Ministry of Health, Malaysia


Uploaded on: Oct 5, 2023
RECOGNISES THE ROLE OF
ADJUVANTS
Adjuvant
 Definition: Various compounds (mineral salts, microbial products, emulsions,
cytokines, liposomes) which enhances the body’s immune response to antigen and
allows vaccines to be more effective
 Administered in conjunction with vaccine to boost immune response
 1st adjuvant discovered in 1926 – Alexander Glenny found mixing aluminum salts
(alum) with antigens and injecting them into guinea pigs induced more antibodies
than administering antigens alone
 Approved adjuvants for humans:
- alum and monophosphoryl lipid A (US)
- MF59 (an oil-and-water emulsion) (Europe, elsewhere
 Mechanisms: enhance the adaptive immunity of vaccines by
i. Formation of depot at site of injection (associated with slow release of antigen)
ii. Induction of cytokines and chemokines
iii. Recruitment of immune cells
iv. Enhancement of antigen uptake and presentation
v. Promoting antigen transport to draining lymph nodes for activation of B cells or T
cells.
Pogostin, Brett H., and Kevin J. McHugh. (2021)
Role of Adjuvant
Increases the Increases the speed and
duration of the immune Strengthens the immune
immunogenicity of
response response
weak antigens

Eliminates antigen Saves money by


Role of
competition in reducing the required
Adjuvant antigen dose
combination vaccines

Increases the antigen Stimulates cellular Increases mucosal


affinity with the body immunity immunity
RECALL PRIMARY AND
SECONDARY IMMUNE RESPONSE
Primary Immune Response
 Occurs after the first exposure to an antigen
 Immune system recognize the antigen, produce antibodies against the antigen and
induce a long-term memory response against the antigen
 Results in the generation of memory lymphocytes

Secondary Immune Response


 Occurs as a result of a subsequent exposure (2nd, 3rd, 4th time) to the same antigen
 This response is mediated by the memory lymphocytes (produced during primary
response)
 The memory lymphocytes immediately produce antibodies
 Antibody production level increase rapidly in a short time
 Antigen will be eliminated quickly before it can cause disease
Vaccines are able to activate the adaptive immune system to create
‘memory' conferring long-lasting immunity specific to the
pathogen.

Memory cells
 Lymphocytes are produced in response to the specific antigens on a pathogen
 After the pathogen is removed, some of the lymphocytes continue to remain in
the immune system – memory cells
 If the same pathogen invaded for the 2nd time, the response is much more rapid
 How? Existing memory cells are able to multiply rapidly, producing clones of
the specific lymphocyte
 Attack and destroy the pathogen before the individual exhibits symptoms
https://www.nagwa.com/en/explainers/530161683752/
Primary Immune Response Secondary Immune Response
Occurs as a result of primary contact with This occurs as a result of second and
an antigen subsequent exposure of the same antigen
Responding cell is naïve B-cell and T-cell. Responding cell is memory cell.
Lag phase longer (4-7 days or weeks, Lag phase is shorter (1-4 days) due to the
months) presence of memory cell.
Level of antibody reaches peak in 7 to 10 Level of antibody reaches peak in 3 to 5
days. days.
It takes longer time to establish immunity. Takes shorter time to establish immunity.
Amount of antibody produced depends on Usually 100-1000 times more antibodies are
nature of antigen. Usually produced in low produced.
amount.
Antibody level declines rapidly. Antibody level remain high for longer
period.
References
1. Active vs. Passive Immunity: Differences and Definition, Nicole Gleichmann & Karen
Steward, PhD (2023);
https://www.technologynetworks.com/immunology/articles/active-vs-passive-immunity-
differences-and-definition-335112
2. Tortora, G. J., Funke, B. R., & Case, C. L. (2019). Microbiology : an introduction
(Thirteenth edition). Pearson.
3. Atif M, Raheel U, Imran M, Arshad HU, Baloch FUH, et al. (2016) Dengue Virus: Host-
Pathogen Interactions and Emerging Role of DNA Vaccines. Journal of Human Virology &
Retrovirology 3(3): 00091. DOI: 10.15406/jhvrv.2016.03.00091
4. Pogostin, Brett H., and Kevin J. McHugh. 2021. "Novel Vaccine Adjuvants as Key Tools for
Improving Pandemic Preparedness" Bioengineering 8, no. 11: 155.
https://doi.org/10.3390/bioengineering8110155
5. Foumani, M.; Asadpour, L.; Azizi Saraji, A.; Sharifat Salmani, A.; Aghasadeghi, M. Adjuvants
and their mechanisms of action. J. Ardabil Univ. Med. Sci. 2012, 12, 276–291.
6. Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013
May 16;4:114. doi: 10.3389/fimmu.2013.00114. PMID: 23720661; PMCID:
PMC3655441.
7. The Malaysian National Immunisation Programme (NIP)https://immunise4life.my/the-
malaysian-national-immunisation-programme-nip/
Covid-19 Vaccines

https://www.immunology.org/public-information/vaccine-resources/covid-19/covid-19-
vaccine-infographics/types-covid19-vaccines

You might also like